
Stryker Corporation
SYKNYSEHealthcareMedical - Devices
Previous close
$329.45
+$1.75 · +0.53%
SYK company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Buy
Favorable setup — positive multi-factor alignment
Valuation
75
Undervalued
Momentum
47
Neutral
Sentiment
71
Bullish
Risk resilience
69
Moderate Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteStryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Kevin A. Lobo
- Listed since
- Mar 17, 1980
- Employees
- 56,000
Market position
Day range
Current $329.45
52-week range
Current $329.45
- Open
- $326.03
- Previous close
- $327.7
- Volume
- 2.42M
- 0.93× average
- Average volume
- 2.61M
- Average daily volume
- Market cap
- 126.3B USD
- Beta
- 0.77
- Market reference 1
- 50-day average
- $326.6
- +0.87% above average
- 200-day average
- $340.48
- -3.24% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 146.68B USD
- EV / EBITDA
- 23.23×
- Earnings yield
- 2.42%
- Free cash flow yield
- 3.19%
Profitability & efficiency
- Return on equity
- 14.48%
- Return on assets
- 6.78%
- Return on invested capital
- 8.53%
Financial health
- Current ratio
- 1.89×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 25.12B USD | 22.6B USD | 20.5B USD | 18.45B USD | 17.11B USD |
| Cost of goods sold | 9.05B USD | 8.62B USD | 8B USD | 7.41B USD | 6.4B USD |
| Gross profit | 16.07B USD | 13.98B USD | 12.49B USD | 11.04B USD | 10.71B USD |
| Research and development | 1.58B USD | 1.41B USD | 1.29B USD | 1.23B USD | 1.13B USD |
| Selling, general, and administrative | 8.65B USD | 7.51B USD | 6.92B USD | 6.08B USD | 5.81B USD |
| Operating expenses | 11.18B USD | 8.92B USD | 8.21B USD | 7.31B USD | 6.95B USD |
| Interest income | 121M USD | 139M USD | 75M USD | 94M USD | 68M USD |
| Interest expense | 607M USD | 396M USD | 356M USD | 337M USD | 337M USD |
| Depreciation and amortization | 1.19B USD | 1.05B USD | 1.03B USD | 998M USD | 990M USD |
| Operating income | 4.89B USD | 5.06B USD | 4.28B USD | 3.73B USD | 3.76B USD |
| Net income | 3.25B USD | 2.99B USD | 3.17B USD | 2.36B USD | 1.99B USD |
Company facts updated Aug 24, 2026.
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$382.61
16.14% upsideSYK peers
ETFs holding SYK
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI3.58B0.16%2.3T USD0.03%$378.24+0.44%
Vanguard S&P 500 ETFVOO2.95B0.17%1.7T USD0.03%$703.71+0.39%
iShares Core S&P 500 ETFIVV1.52B0.17%891.84B USD0.03%$769.31+0.39%
State Street SPDR S&P 500 ETFSPY1.4B0.17%817.87B USD0.09%$765.72+0.41%
State Street Health Care Select Sector SPDR ETFXLV813.32M1.82%44.76B USD0.08%$174.62+1.29%
Vanguard Morningstar Growth ETFVUG651.74M0.17%372B USD0.03%$87.50+0.38%
Vanguard Dividend Appreciation ETFVIG635.81M0.48%130.9B USD0.04%$243.91+0.69%
Vanguard Morningstar Value ETFVTV535.12M0.21%256.5B USD0.03%$226.4+0.54%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 3.58B
- Weight
- 0.16%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard S&P 500 ETFVOO- Market value
- 2.95B
- Weight
- 0.17%
- AUM
- 1.7T USD
- Expense ratio
- 0.03%
- Price / 1D
- $703.71+0.39%
iShares Core S&P 500 ETFIVV- Market value
- 1.52B
- Weight
- 0.17%
- AUM
- 891.84B USD
- Expense ratio
- 0.03%
- Price / 1D
- $769.31+0.39%
State Street SPDR S&P 500 ETFSPY- Market value
- 1.4B
- Weight
- 0.17%
- AUM
- 817.87B USD
- Expense ratio
- 0.09%
- Price / 1D
- $765.72+0.41%
State Street Health Care Select Sector SPDR ETFXLV- Market value
- 813.32M
- Weight
- 1.82%
- AUM
- 44.76B USD
- Expense ratio
- 0.08%
- Price / 1D
- $174.62+1.29%
Vanguard Morningstar Growth ETFVUG- Market value
- 651.74M
- Weight
- 0.17%
- AUM
- 372B USD
- Expense ratio
- 0.03%
- Price / 1D
- $87.50+0.38%
Vanguard Dividend Appreciation ETFVIG- Market value
- 635.81M
- Weight
- 0.48%
- AUM
- 130.9B USD
- Expense ratio
- 0.04%
- Price / 1D
- $243.91+0.69%
Vanguard Morningstar Value ETFVTV- Market value
- 535.12M
- Weight
- 0.21%
- AUM
- 256.5B USD
- Expense ratio
- 0.03%
- Price / 1D
- $226.4+0.54%
Continue in GoAI
Research SYKresearch.disclaimer





